Support resources and services for the use of annotated patient-derived (PD) models including xenografts (PDX) and organoids (PDO) models for research that make an impact in precision cancer medicine.
Research, development and technological transfer in the life sciences, including pharmaceuticals, agri-food, natural health products, cosmetics and the environment.